Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028948 · ClinicalTrials.gov registry record · NA
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
A NA study of Stage IIIA Skin Melanoma and Stage 0 Skin Melanoma, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 485
- Enrollment target
- 2
- Study locations
NCT03028948: Completed NA study of Stage IIIA Skin Melanoma and Stage 0 Skin Melanoma, sponsored by Rutgers, The State University of New Jersey.
NCT03028948 is a NA study of Stage IIIA Skin Melanoma and Stage 0 Skin Melanoma that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 485 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03028948, a NA study of Stage IIIA Skin Melanoma and Stage 0 Skin Melanoma, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 485 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial studies how well an interactive tailored website works in promoting sun protection and skin self-check behaviors in patients with stage 0-III melanoma. An internet-based program may help individuals to perform skin self-checks and engage in sun protection behaviors.
Primary Outcome
Participants rated how often they engaged in four behaviors when outside on a sunny day: wearing sun screen with an Sun Protection Factor ≥ 30, wearing a long-sleeved shirt, wearing a wide-brimmed hat, and staying in the shade. Items were rated on a five-point Likert scale (1=never, 2= rarely, 3= sometimes, 4= often, 5=always). In this case, higher values are associated with more protection behaviors. Subscales were averaged to compute the total index score.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Questionnaire Administration
- OTHER Internet-Based Intervention
Study Locations (2)
New Jersey
- Rutgers Cancer Institute of New Jersey - New Brunswick
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 485 participants |
| Start Date | 2017-01-13 |
| Est. Completion | 2020-08-29 |
| Phase | NA |
What the finished NCT03028948 record still lists
NCT03028948 is an interventional study that assigns participants to a tested intervention. The registered 485 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 10 conditions, with Stage IIIA Skin Melanoma appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT03028948 reports a single indexed study location in New Jersey, Virginia.
Frequently Asked Questions
What is clinical trial NCT03028948 about?
NCT03028948 is a clinical study titled "Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma". This clinical trial studies how well an interactive tailored website works in promoting sun protection and skin self-check behaviors in patients with stage 0-III melanoma. An internet-based program may help individuals to perform skin self-checks and engage in sun protection behaviors.
What is the current status of trial NCT03028948?
This trial is currently completed. It is a NA study. The enrollment target is 485 participants. The study started on 2017-01-13. Estimated completion is 2020-08-29.
What conditions does trial NCT03028948 study?
This clinical trial studies the following conditions: Stage IIIA Skin Melanoma, Stage 0 Skin Melanoma, Stage I Skin Melanoma, Stage IA Skin Melanoma, Stage IB Skin Melanoma.
What interventions are being tested in trial NCT03028948?
The interventions under investigation include: Survey Administration (OTHER), Questionnaire Administration (OTHER), Internet-Based Intervention (OTHER).
Who is sponsoring clinical trial NCT03028948?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03028948 being conducted?
This trial has 2 study locations across New Jersey, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IIIA Skin Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03028948's enrollment target sits among peer trials
485 216th of 2000 higher than 1,785 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy
ACTIVE NOT RECRUITING · Phase 2
-
Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07124910 · 485 participants · Phase 3
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
- NCT06420531 · 486 participants · NA
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
- NCT07097142 · 486 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI